CUPRIOR

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, UK.

Active ingredients

The drug CUPRIOR contains one active pharmaceutical ingredient (API):

1	Trientine UNII 7360URE56Q - TRIENTINE TETRAHYDROCHLORIDE
	Trientine is a copper-chelating agent whose principal mechanism of action is to eliminate absorbed copper from the body by forming a stable complex that is then eliminated through urinary excretion. Trientine may also chelate copper in the intestinal tract and so inhibit copper absorption.
	Read more about Trientine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CUPRIOR Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A16AX12		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AX Various alimentary tract and metabolism products
Discover more medicines within A16AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1752959, 1829594
FI	Lääkealan turvallisuus- ja kehittämiskeskus	523961
FR	Base de données publique des médicaments	66671295
GB	Medicines & Healthcare Products Regulatory Agency	370820
IE	Health Products Regulatory Authority	89008
LT	Valstybinė vaistų kontrolės tarnyba	1083793, 1088644
NL	Z-Index G-Standaard, PRK	197572
NZ	Medicines and Medical Devices Safety Authority	20930
PL	Rejestru Produktów Leczniczych	100400334
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68892001